Oncotarget

Research Papers:

Melanoma-initiating cells exploit M2 macrophage TGFβ and arginase pathway for survival and proliferation

Muly Tham _, Kar Wai Tan, Jo Keeble, Xiaojie Wang, Sandra Hubert, Luke Barron, Nguan Soon Tan, Masashi Kato, Armelle Prevost-Blondel, Veronique Angeli and Jean-Pierre Abastado

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2014; 5:12027-12042. https://doi.org/10.18632/oncotarget.2482

Metrics: PDF 2386 views  |   HTML 3741 views  |   ?  


Abstract

Muly Tham1, Kar Wai Tan1,7, Jo Keeble1, Xiaojie Wang1, Sandra Hubert1, Luke Barron2, Nguan Soon Tan3, Masashi Kato4, Armelle Prevost-Blondel5, Veronique Angeli6 and Jean-Pierre Abastado1,8

1 Singapore Immunology Network, BMSI, A-STAR, Singapore

2 Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

3 School of Biological Sciences, Nanyang Technological University, Singapore

4 Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Japan

5 Institut Cochin, Université Paris Descartes, CNRS UMR, Paris, France

6 Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

7 Department of Clinical Research, Singapore General Hospital, Singapore

8 Institut de Recherche Internationales Servier, 50 rue Carnot, Suresnes cedex, France

Correspondence:

Muly Tham, email:

Keywords: Arginase, Macrophages, TGFβ, Tumor-initiating cell

Received: July 13, 2014 Accepted: September 15, 2014 Published: September 16, 2014

Abstract

M2 macrophages promote tumor growth and metastasis, but their interactions with specific tumor cell populations are poorly characterized. Using a mouse model of spontaneous melanoma, we showed that CD34- but not CD34+ tumor-initiating cells (TICs) depend on M2 macrophages for survival and proliferation. Tumor-associated macrophages (TAMs) and macrophage-conditioned media protected CD34- TICs from chemotherapy in vitro. In vivo, while inhibition of CD115 suppressed the macrophage-dependent CD34- TIC population, chemotherapy accelerated its development. The ability of TICs to respond to TAMs was acquired during melanoma progression and immediately preceded a surge in metastatic outgrowth. TAM-derived transforming growth factor-β (TGFβ) and polyamines produced via the Arginase pathway were critical for stimulation of TICs and synergized to promote their growth.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 2482